Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PROPRANOLOL 20MG TABLET Resolved 2023-06-16 2023-07-06 195240
TEVA-PROPRANOLOL 80MG TABLET Resolved 2023-06-19 2023-07-05 195498
TEVA-PROPRANOLOL 40MG TABLET Resolved 2023-06-19 2023-07-05 195612
TEVA-PROPRANOLOL 80MG TABLET Resolved 2023-06-20 2023-07-05 195760
TEVA-PROPRANOLOL 20MG TABLET Resolved 2023-06-20 2023-07-06 195809
TEVA-PROPRANOLOL 40MG TABLET Resolved 2023-06-20 2023-07-05 195821
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1748
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-11 1760
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2018-02-21 1769
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-16 2018-05-30 43168
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-12 2019-10-04 93656
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-19 2019-10-04 94375
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-06 2020-05-21 107986
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-12 2020-06-04 108607
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2020-09-17 120485

Showing 2081 to 2100 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
ACT RIZATRIPTAN 10MG TABLET Discontinued 2021-07-22 2021-07-22 142912
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Discontinued 2019-08-08 2019-08-08 91175
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2021-02-12 2021-02-12 133886
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940

Showing 41 to 60 of 250